Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2025 06:00 ET | Source: Fangzhou Inc.

Fangzhou’s “XingJie” LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations

Fangzhou was presented with a Generative AI Service Filing Certificate at the first Guangdong Provincial LLM Filing Conference.
October 29, 2025 05:56 ET | Source: Fangzhou Inc.

Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management

Fangzhou and Fosun Pharma plan to build partnership in AI-powered chronic disease management, initially focused on psoriasis and other autoimmune condition
October 22, 2025 11:19 ET | Source: Fangzhou Inc.

Fangzhou Unveils “AI + Weight Management” Innovation at China’s Inaugural National-Level Weight Management Symposium in Beijing

Fangzhou plans to expand its "AI + Weight Management" ecosystem through broader applications, data-driven innovation, and cross-industry collaboration.
September 26, 2025 03:47 ET | Source: Fangzhou Inc.

Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care

Fangzhou's “XingShi” Large Language Model (“XS LLM”) was featured by Nature News.
September 17, 2025 22:44 ET | Source: Fangzhou Inc.

Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025

was recognized as an “Outstanding Growth Story in Hong Kong Stocks”
September 17, 2025 21:16 ET | Source: Fangzhou Inc.

Fangzhou Wins Gilead ‘Award of Excellence’ for AI-Driven Chronic Disease Management

Fangzhou received the “Excellence Award” at Gilead Sciences, Inc.’s (“Gilead”) 2025 Multi-Channel Conference in Shanghai.
September 14, 2025 08:32 ET | Source: Fangzhou Inc.

Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic Disease Management

Fangzhou announced the release of its proprietary “XingShi” Large Language Model.
September 10, 2025 04:29 ET | Source: Fangzhou Inc.

Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions

Fangzhou signed a strategic partnership with Innovent Biologics to integrate digital health services with innovative therapies.
September 03, 2025 03:45 ET | Source: Fangzhou Inc.

Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research

Fangzhou is not only driving commercial success through AI-driven healthcare, but also contributing to China’s broader innovation agenda.
August 27, 2025 11:52 ET | Source: Fangzhou Inc.

Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand

Fangzhou Inc. reported a profitable first half of 2025, supported by an expanding user base, higher operating efficiency, and accelerated deployment of AI.